Activation of the intrarenal renin-angiotensin-system in murine polycystic kidney disease

Physiological Reports

Volumn 3, Issue 5, 2015, Pages

  Saigusa, Takamitsu ^a   Dang, Yujing ^a   Bunni, Marlene A ^a   Amria, May Y ^a   Steele, Stacy L ^a   Fitzgibbon, Wayne R ^a   Bell, P Darwin ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

ADPKD; Hypertension; Intratubular RAS; Primary cilium

Indexed keywords

ALBUMIN; ANGIOTENSINOGEN; CREATININE; CYCLIC AMP; GLUCOSE; POLYCYSTIN 1; PRORENIN; PRORENIN RECEPTOR; TAMOXIFEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAMP ASSAY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE INACTIVATION; HISTOLOGY; IMMUNOFLUORESCENCE; KIDNEY CYST; KIDNEY MASS; KIDNEY POLYCYSTIC DISEASE; MALE; MOUSE; NONHUMAN; ONCOGENE RAS; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIMIAN VIRUS 40; SYSTOLIC BLOOD PRESSURE; UPREGULATION; WESTERN BLOTTING;

EID: 85006139555     PISSN: None     EISSN: 2051817X     Source Type: Journal    
DOI: 10.14814/phy2.12405     Document Type: Article

References (49)

1. Belibi, F. A., and C. L. Edelstein. 2010. Novel targets for the treatment of autosomal dominant polycystic kidney disease. Expert Opin. Investig. Drugs 19:315–328.
2. Belibi, F. A., G. Reif, D. P. Wallace, T. Yamaguchi, L. Olsen, H. Li, et al. 2004. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int. 66:964–973.
3. Bell, P. D., W. Fitzgibbon, K. Sas, A. E. Stenbit, M. Amria, A. Houston, et al. 2011. Loss of primary cilia upregulates renal hypertrophic signaling and promotes cystogenesis. J. Am. Soc. Nephrol. 22:839–848.
4. Burns, K. D., L. Regnier, A. Roczniak, and R. L. Hébert. 1996. Immortalized rabbit cortical collecting duct cells express AT1 angiotensin II receptors. Am. J. Physiol. 271:F1147–F1157.
5. Cao, Z., and M. E. Cooper. 2001. Role of angiotensin II in tubulointerstitial injury. Semin. Nephrol. 21:554–562.
6. Chapman, A. B., A. Johnson, P. A. Gabow, and R. W. Schrier. 1990. The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N. Engl. J. Med. 323:1091–1096.
7. Chapman, A. B., K. Stepniakowski, and F. Rahbari-Oskoui. 2010. Hypertension in autosomal dominant polycystic kidney disease. Adv. Chronic Kidney Dis. 17:153–163.
8. Coaxum, S. D., M. G. Blanton, A. Joyner, T. Akter, P. D. Bell, L. M. Luttrell, et al. 2014. Epidermal growth factor-induced proliferation of collecting duct cells from Oak Ridge polycystic kidney mice involves activation of Na+/H+ exchanger. Am. J. Physiol. Cell Physiol. 307:C554–C560.
9. Davenport, J. R., A. J. Watts, V. C. Roper, M. J. Croyle, T. van Groen, J. M. Wyss, et al. 2007. Disruption of intraflagellar transport in adult mice leads to obesity and slow-onset cystic kidney disease. Curr. Biol. 17:1586–1594.
10. Doulton, T. W., A. K. Saggar-Malik, F. J. He, C. Carney, N. D. Markandu, G. A. Sagnella, et al. 2006. The effect of sodium and angiotensin-converting enzyme inhibition on the classic circulating renin-angiotensin system in autosomal-dominant polycystic kidney disease patients. J. Hypertens. 24:939–945.
11. Du, J., and P. D. Wilson. 1995. Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD. Am. J. Physiol. 269:C487–C495.
12. Goto, M., N. Hoxha, R. Osman, and K. M. Dell. 2010. The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease. Pediatr. Nephrol. 25:2449–2457.
13. Graham, P. C., and G. B. Lindop. 1988. The anatomy of the renin-secreting cell in adult polycystic kidney disease. Kidney Int. 33:1084–1090.
14. Guay-Woodford, L. M., J. J. Bissler, M. C. Braun, D. Bockenhauer, M. A. Cadnapaphornchai, K. M. Dell, et al. 2014. Consensus expert recommendations for the diagnosis and management of autosomal recessive polycystic kidney disease: report of an international conference. J. Pediatr. 165:611–617.
15. Hayashi, S., and A. P. McMahon. 2002. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/ inactivation in the mouse. Dev. Biol. 244:305–318.
16. Haycraft, C. J., Q. Zhang, B. Song, W. S. Jackson, P. J. Detloff, R. Serra, et al. 2007. Intraflagellar transport is essential for endochondral bone formation. Development 134:307–316.
17. Jan Danser, A. H., W. W. Batenburg, and J. H. van Esch. 2007. Prorenin and the (pro)renin receptor–an update. Nephrol. Dial. Transplant. 22:1288–1292.
18. Kang, J. J., I. Toma, A. Sipos, E. J. Meer, S. L. Vargas, and J. Peti-Peterdi. 2008. The collecting duct is the major source of prorenin in diabetes. Hypertension 51:1597–1604.
19. Kaplan, B. S., J. Fay, V. Shah, M. J. Dillon, and T. M. Barratt. 1989. Autosomal recessive polycystic kidney disease. Pediatr. Nephrol. 3:43–49.
20. Kennefick, T. M., M. A. Al-Nimri, T. T. Oyama, M. M. Thompson, F. J. Kelly, J. G. Chapman, et al. 1999. Hypertension and renal injury in experimental polycystic kidney disease. Kidney Int. 56:2181–2190.
21. Kim, K., I. Drummond, O. Ibraghimov-Beskrovnaya, K. Klinger, and M. A. Arnaout. 2000. Polycystin 1 is required for the structural integrity of blood vessels. Proc. Natl Acad. Sci. USA 97:1731–1736.
22. Kobori, H., L. M. Harrison-Bernard, and L. G. Navar. 2002. Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int. 61:579–585.
23. Kobori, H., M. Nangaku, L. G. Navar, and A. Nishiyama. 2007. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol. Rev. 59:251–287.
24. Lawson, C. R., T. W. Doulton, and G. A. MacGregor. 2006. Autosomal dominant polycystic kidney disease: role of the renin-angiotensin system in raised blood pressure in progression of renal and cardiovascular disease. J. Renin Angiotensin Aldosterone Syst. 7:139–145.
25. Lehman, J. M., E. J. Michaud, T. R. Schoeb, Y. Aydin-Son, M. Miller, and B. K. Yoder. 2008. The Oak Ridge Polycystic Kidney mouse: modeling ciliopathies of mice and men. Dev. Dyn. 237:1960–1971.
26. Li, C., W. Wang, C. J. Rivard, M. A. Lanaspa, S. Summer, and R. W. Schrier. 2011. Molecular mechanisms of angiotensin II stimulation on aquaporin-2 expression and trafficking. Am. J. Physiol. Renal. Physiol. 300:F1255–F1261.
27. Liu, L., A. A. Gonzalez, M. McCormack, D. M. Seth, H. Kobori, L. G. Navar, et al. 2011. Increased renin excretion is associated with augmented urinary angiotensin II levels in chronic angiotensin II-infused hypertensive rats. Am. J. Physiol. Renal. Physiol. 301:F1195–F1201.
28. Loghman-Adham, M., C. E. Soto, T. Inagami, and L. Cassis. 2004. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease. Am. J. Physiol. Renal. Physiol. 287:F775–F788.
29. Loghman-Adham, M., C. E. Soto, T. Inagami, and C. Sotelo- Avila. 2005. Expression of components of the reninangiotensin system in autosomal recessive polycystic kidney disease. J. Histochem. Cytochem. 53:979–988.
30. Ludwig, J., S. Kerscher, U. Brandt, K. Pfeiffer, F. Getlawi, D. K. Apps, et al. 1998. Identification and characterization of a novel 9.2-kDa membrane sector-associated protein of vacuolar proton-ATPase from chromaffin granules. J. Biol. Chem. 273:10939–10947.
31. Luetscher, J. A., F. B. Kraemer, D. M. Wilson, H. C. Schwartz, and M. Bryer-Ash. 1985. Increased plasma inactive renin in diabetes mellitus. A marker of microvascular complications. N. Engl. J. Med. 312:1412–1417.
32. Mercure, C., G. Prescott, M. J. Lacombe, D. W. Silversides, and T. L. Reudelhuber. 2009. Chronic increases in circulating prorenin are not associated with renal or cardiac pathologies. Hypertension 53:1062–1069.
33. Nauli, S. M., Y. Kawanabe, J. J. Kaminski, W. J. Pearce, D. E. Ingber, and J. Zhou. 2008. Endothelial cilia are fluid shear sensors that regulate calcium signaling and nitric oxide production through polycystin-1. Circulation 117:1161–1171.
34. Olteanu, D., B. K. Yoder, W. Liu, M. J. Croyle, E. A. Welty, K. Rosborough, et al. 2006. Heightened epithelial Na+ channelmediated Na+ absorption in a murine polycystic kidney disease model epithelium lacking apical monocilia. Am. J. Physiol. Cell Physiol. 290:C952–C963.
35. Piontek, K., L. F. Menezes, M. A. Garcia-Gonzalez, D. L. Huso, and G. G. Germino. 2007. A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat. Med. 13:1490–1495.
36. Piontek, K. B., D. L. Huso, A. Grinberg, L. Liu, D. Bedja, H. Zhao, et al. 2004. A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo. J. Am. Soc. Nephrol. 15:3035–3043.
37. Prieto-Carrasquero, M. C., H. Kobori, Y. Ozawa, A. Gutiérrez, D. Seth, and L. G. Navar. 2005. AT1 receptor-mediated enhancement of collecting duct renin in angiotensin IIdependent hypertensive rats. Am. J. Physiol. Renal. Physiol. 289:F632–F637.
38. Saigusa, T., and P. D. Bell. 2015. Molecular pathways and therapies in autosomal-dominant polycystic kidney disease. Physiology (Bethesda) 30:195–207.
39. Saigusa, T., R. Reichert, J. Guare, B. J. Siroky, M. Gooz, S. Steele, et al. 2012. Collecting duct cells that lack normal cilia have mislocalized vasopressin-2 receptors. Am. J. Physiol. Renal. Physiol. 302:F801–F808.
40. Sas, K. M., M. G. Janech, E. Favre, J. M. Arthur, and P. D. Bell. 2011. Cilia movement regulates expression of the Raf-1 kinase inhibitor protein. Am. J. Physiol. Renal. Physiol. 300: F1163–F1170.
41. Siroky, B. J., W. B. Ferguson, A. L. Fuson, Y. Xie, A. Fintha, P. Komlosi, et al. 2006a. Loss of primary cilia results in deregulated and unabated apical calcium entry in ARPKD collecting duct cells. Am. J. Physiol. Renal. Physiol. 290: F1320–F1328.
42. Siroky, B. J., and L. M. Guay-Woodford. 2006b. Renal cystic disease: the role of the primary cilium/centrosome complex in pathogenesis. Adv. Chronic Kidney Dis. 13:131–137.
43. Stankovic, A. R., N. D. Fisher, and N. K. Hollenberg. 2006. Prorenin and angiotensin-dependent renal vasoconstriction in type 1 and type 2 diabetes. J. Am. Soc. Nephrol. 17:3293–3299.
44. Torres, V. E., Y. Cai, X. Chen, G. Q. Wu, L. Geng, K. A. Cleghorn, et al. 2001. Vascular expression of polycystin-2. J. Am. Soc. Nephrol. 12:1–9.
45. Torres, V. E., K. A. Donovan, G. Scicli, K. E. Holley, S. N. Thibodeau, O. A. Carretero, et al. 1992. Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease. Kidney Int. 42:364–373.
46. Veizis, E. I., C. R. Carlin, and C. U. Cotton. 2004. Decreased amiloride-sensitive Na+ absorption in collecting duct principal cells isolated from BPK ARPKD mice. Am. J. Physiol. Renal. Physiol. 286:F244–F254.
47. Wilson, P. D., O. Devuyst, X. Li, L. Gatti, D. Falkenstein, S. Robinson, et al. 2000. Apical plasma membrane mispolarization of NaK-ATPase in polycystic kidney disease epithelia is associated with aberrant expression of the beta2 isoform. Am. J. Pathol. 156:253–268.
48. Wong, N. L., and J. K. Tsui. 2003. Angiotensin II upregulates the expression of vasopressin V2 mRNA in the inner medullary collecting duct of the rat. Metabolism 52:290–295.
49. Yoder, B. K., A. Tousson, L. Millican, J. H. Wu, C. E. Jr. Bugg, J. A. Schafer, et al. 2002. Polaris, a protein disrupted in orpk mutant mice, is required for assembly of renal cilium. Am. J. Physiol. Renal. Physiol. 282:F541–F552.